Evidence map›Paper›PMID 37265829›Full record

ArticleMalawi medical journal : the journal of Medical Association of Malawi2022

Factors affecting the failure of High Flow Nasal Cannula Oxygen therapy in Intensive Care follow-up of COVID-19 Severe Respiratory Failure.

Çiyiltepe Fulya, Kahraman Ersin, Geçici Mehmet, Bilir Yeliz, Bombacı Elif, Saraçoğlu Kemal

Open access · diamondAbstract read
In one paragraph

Article in Malawi medical journal : the journal of Medical Association of Malawi, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Çiyiltepe FulyaIstanbul Kartal Dr. Lütfi Kırdar City Hospital, Department of Anesthesiology and Reanimation.
Kahraman ErsinIstanbul Kartal Dr. Lütfi Kırdar City Hospital, Department of Anesthesiology and Reanimation.
Geçici MehmetIstanbul Kartal Dr. Lütfi Kırdar City Hospital, Department of Anesthesiology and Reanimation.
Bilir YelizIstanbul Kartal Dr. Lütfi Kırdar City Hospital, Department of Anesthesiology and Reanimation.
Bombacı ElifIstanbul Kartal Dr. Lütfi Kırdar City Hospital, Department of Anesthesiology and Reanimation.
Saraçoğlu KemalIstanbul Kartal Dr. Lütfi Kırdar City Hospital, Department of Anesthesiology and Reanimation.
Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Acute respiratory distress syndrome is the primary clinical problem that requires follow-up at the intensive care units. High Flow Nasal Cannula Oxygen Therapy has become an increasingly popular method by reducing the need for intubation but determining which patient will benefit from High Flow Nasal Cannula Oxygen Therapy is an important issue. Methods: Seventy patients who followed up with acute respiratory distress syndrome related COVID-19 treated with High Flow Nasal Cannula Oxygen Systems as initial treatment at the intensive care units were retrospectively review. The primary endpoint of this study is to identify factors correlating with failure (mortality and invasive mechanical ventilator requirement) of High Flow Nasal Cannula Oxygen Therapy in the treatment of COVID-19-related severe ARDS. The secondary aim of this study is to determine the ROX index measured at the 12th hour, which will indicate the need for intubation in critically ill patients followed up with HFNC. Results: Advanced age, male gender, and low ROX index were independent variables affecting High Flow Nasal Cannula Oxygen Therapy failure. While mortality was lowest in patients who completed the process with High Flow Nasal Cannula Oxygen Therapy treatment, patients who were intubated early (12-24h) had lower mortality than those who were intubated later (>24h) (Mortality rates were %4,3 ,%65,6 ,%93,3 respectively). The cut-off value for ROX index, which will indicate the need for intubation, was found to be 2.84. Conclusion: High Flow Nasal Cannula Oxygen Therapy can be an effective treatment method in the follow-up of patients with COVID-19-related severe respiratory failure. Despite this, the requirement for intubation develops in two third of the patients. Early intubation reduces mortality in patients who fail High Flow Nasal Cannula Oxygen Therapy, and the easily calculated ROX index is a useful parameter to determine the need for intubation.

Indexed as

COVID-19Respiratory Distress SyndromeRespiratory InsufficiencyCannulaCritical CareFollow-Up StudiesHumansMaleOxygenOxygen Inhalation TherapyRetrospective StudiesOxygenCOVID-19high-flow nasal cannula oxygen therapyintensive care unitspredictive factorROX indexsevere ARDS

Identifiers

PMID37265829
PMCPMC10230580
OpenAlexW4224128274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.